As of July 1 2015, it is mandatory to submit centralized procedure applications for human medicines to the EMA via eSubmission Gateway/Web Client. These applications will automatically be made available to all national competent authorities via a common online repository. Companies should therefore no longer send centralized procedure applications for human medicines to individual Member States on CDs/DVDs or via the Common European Submission Platform. The common repository, available since February 2014, is aimed at accelerating the validation of incoming applications.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
